SCHEMBL27816448

SCHEMBL27816448

Nc1nc(N)c2ncn(-c3ccc(-c4nccs4)cc3)c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 2/20 0.42
▸ LOXL2 Q9Y4K0 1/20 0.41
▸ PI4KA P42356 4/20 0.39
▸ PI4K2B Q8TCG2 4/20 0.39
▸ PI4K2A Q9BTU6 4/20 0.39
▸ PI4KB Q9UBF8 4/20 0.39
▸ CDK1 P06493 2/20 0.39
▸ CCNB1 P14635 2/20 0.39
▸ CCNE1 P24864 2/20 0.39
▸ CDK2 P24941 2/20 0.39
▸ ADORA2A P29274 2/20 0.39
▸ PDPK1 O15530 1/20 0.39
▸ EGFR P00533 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ DHFR P00374 1/20 0.38
▸ ADORA1 P30542 1/20 0.37
▸ HDAC3 O15379 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28230093 0.76 CDK1 (0.48) CFTRPI4KAPI4K2BPI4K2API4KB
SCHEMBL27886646 0.76 CFTR (0.49) CFTRPI4KAPI4K2BPI4K2API4KB
SCHEMBL27870411 0.76 CFTR (0.49) CFTRPI4KAPI4K2BPI4K2API4KB
SCHEMBL27870413 0.76 XDH (0.58) CFTRPI4KAPI4K2BPI4K2API4KB
SCHEMBL27886637 0.75 PI4KA (0.64) CFTRPI4KAPI4K2BPI4K2API4KB
SCHEMBL17802613 0.75 CFTR (0.49) CFTRPI4KAPI4K2BPI4K2API4KB
SCHEMBL28861601 0.72 PI4KA (0.68) CFTRPI4KAPI4K2BPI4K2API4KB
SCHEMBL17802588 0.71 CFTR (0.76) CFTRPI4KAPI4K2BPI4K2API4KB
SCHEMBL13557085 0.68 PI4KA (0.43) CFTRPI4KAPI4K2BPI4K2API4KB
SCHEMBL722198 0.67 PDPK1 (0.77) LOXL2ADORA2APDPK1HSP90AA1ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1946405-B Use of 9h-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9h-purine-2,6-diamine derivatives NOVARTIS AG 2010-10-13 — — CN disclosed
Send feedback